首页> 外文期刊>Methods and Protocols >Predictable Peptide Conjugation Ratios by Activation of Proteins with Succinimidyl Iodoacetate (SIA)
【24h】

Predictable Peptide Conjugation Ratios by Activation of Proteins with Succinimidyl Iodoacetate (SIA)

机译:通过用琥珀酰亚胺碘代乙酸盐(SIA)激活蛋白质可预测的肽结合率

获取原文
           

摘要

The small heterobifunctional linker succinimidyl iodoacetate (SIA) was examined for the preparation of peptidea??protein bioconjugates with predicable conjugation ratios. For many conjugation protocols, the protein is either treated with a reductant to cleave disulfide bonds or is reacted with thiolation chemicals, such as Trauta??s reagent. Both approaches are difficult to control, need individual optimization and often lead to unsatisfactory results. In another popular approach, a heterobifunctional linker with a N-hydroxysuccinimide (NHS) and a maleimide functionality is applied to the protein. After the activation of some lysine ?μ-amino groups with the NHS ester functionality, a cysteine-containing peptide is attached to the activated carrier protein via maleimide. Particularly, the maleimide reaction leads to some unwanted byproducts or even cleavage of the linker. Many protocols end up with conjugates with unpredictable and irreproducible conjugation ratios. In addition, the maleimide-thiol addition product should be assumed immunogenic in vivo. To avoid these and other disadvantages of the maleimide approach, we examined the known linker succinimidyl iodoacetate (SIA) in more detail and developed two protocols, which lead to peptidea??protein conjugates with predefined average conjugation ratios. This holds potential to eliminate tedious and expensive optimization steps for the synthesis of a bioconjugate of optimal composition.
机译:检查了小的异双功能连接基琥珀酰亚胺碘乙酸酯(SIA),以制备具有可预见的结合比的肽α-蛋白质生物结合物。对于许多缀合方案,蛋白质要么用还原剂处理以切割二硫键,要么与硫醇化化学试剂(例如Trauta试剂)反应。两种方法都难以控制,需要进行个体优化,并且经常导致不令人满意的结果。在另一种流行的方法中,将具有N-羟基琥珀酰亚胺(NHS)和马来酰亚胺官能团的异双功能接头应用于蛋白质。用NHS酯官能团激活一些赖氨酸β-氨基基团后,含半胱氨酸的肽通过马来酰亚胺连接到活化的载体蛋白上。特别地,马来酰亚胺反应导致一些不希望的副产物或什至裂解连接基。许多协议最终都具有无法预测和不可再现的结合比率的结合物。另外,应假定马来酰亚胺-硫醇加成产物在体内具有免疫原性。为了避免马来酰亚胺方法的这些和其他缺点,我们更详细地研究了已知的接头琥珀酰亚胺碘代乙酸盐(SIA),并开发了两种方案,它们产生具有预定平均缀合比的肽α-蛋白缀合物。这具有消除用于合成最佳组成的生物缀合物的繁琐且昂贵的优化步骤的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号